Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"

Exclusion Criteria

• •1. Patient whose the following severe respiratory disease: pneumonia, uncontrolled asthma, pancreatic fibrosis viral influenza, tuberculosis
• •2. Patient whose the following disease: malignant tumors, severe central nervous system disorders, medication needed severe metabolic disorders
• •3. Patient whose fructose intolerance
• •4. Patient who has hypersensitivity anamnesis of Prospan syrup
• •5. Patient whose heart function is abnormal: cardiac insufficiency, including the case of showing abnormal EKG test value that is clinically significant
• •6. Patient whose liver or kidney function is serious abnormal: including the cases of ALT, AST, bilirubin and blood creatinine value exceeding three times of their upper limit, severe liver disorders, chronic kidney disease
• •7. Patient who has uncontrolled diabetes or uncontrolled hypertensions
• •8. Patient who has experience to have participated in other clinical trial within two months before starting the trial
• •9. Pregnant women, lactating women